Form 4: AIM ImmunoTech Director Nancy Bryan Acquires Shares as Part of Compensation Plan

Director Nancy Bryan acquired 22,645 shares of AIM ImmunoTech stock as part of a compensation plan.

Summary

• Nancy Bryan, a director at AIM ImmunoTech, acquired 22,645 shares of common stock on December 2, 2024.
• The shares were acquired at a price of $0.23 per share.
• This transaction increased her total direct holdings to 61,107 shares.
• The shares were issued in lieu of director compensation under the company's Cash Conservation Plan.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation. It is neither overwhelmingly positive nor negative, but shows alignment of interests.

Positives

• The acquisition of shares by a director demonstrates alignment of interests with shareholders.
• The use of shares for compensation helps the company conserve cash.

Management Comments

• These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.

Industry Context

This type of transaction is common for companies looking to conserve cash, especially in the biotech sector where funding can be volatile. It aligns director interests with shareholders.

Comparison to Industry Standards

• Issuing shares in lieu of cash compensation is a common practice among smaller biotech companies, especially those in the development stage, such as AIM ImmunoTech.
• This approach is often used to preserve cash reserves for research and development activities.
• Other companies in the biotech sector, such as Novavax and Inovio, have also used similar strategies to manage their cash flow.

Stakeholder Impact

• Shareholders may view this as a positive sign of director commitment and cost management.
• Employees may see this as a sign of the company's focus on financial prudence.

Key Dates

Keywords

AIM ImmunoTech, Director, Share Acquisition, Compensation, Cash Conservation Plan, Insider Trading, Form 4